Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease (Q39435765)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease (English)

1 reference

Europe PubMed Central

11 September 2017

0 references

inflammatory bowel diseases

0 references

Clostridium difficile

0 references

0 references

7

object named as

Douglas Rex

1 reference

Europe PubMed Central

11 September 2017

15

object named as

Huiping Xu

1 reference

Europe PubMed Central

11 September 2017

1

object named as

Monika Fischer

1 reference

Europe PubMed Central

11 September 2017

author name string

Dina Kao

2

1 reference

Europe PubMed Central

11 September 2017

Colleen Kelly

3

1 reference

Europe PubMed Central

11 September 2017

Aishwarya Kuchipudi

4

1 reference

Europe PubMed Central

11 September 2017

Syed-Mohammed Jafri

5

1 reference

Europe PubMed Central

11 September 2017

Mark Blumenkehl

6

1 reference

Europe PubMed Central

11 September 2017

Mark Mellow

8

1 reference

Europe PubMed Central

11 September 2017

Nirmal Kaur

9

1 reference

Europe PubMed Central

11 September 2017

Harry Sokol

10

1 reference

Europe PubMed Central

11 September 2017

Gwen Cook

11

1 reference

Europe PubMed Central

11 September 2017

Matthew J Hamilton

12

1 reference

Europe PubMed Central

11 September 2017

Emmalee Phelps

13

1 reference

Europe PubMed Central

11 September 2017

Brian Sipe

14

1 reference

Europe PubMed Central

11 September 2017

Jessica R Allegretti

16

1 reference

Europe PubMed Central

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 August 2016

1 reference

Europe PubMed Central

11 September 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

11 September 2017

22

1 reference

Europe PubMed Central

11 September 2017

10

1 reference

Europe PubMed Central

11 September 2017

2402-2409

1 reference

Europe PubMed Central

11 September 2017

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Clostridium difficile infection: epidemiology, risk factors and management

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Clostridium difficile infection: new developments in epidemiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Clostridium difficile infections in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Treating Clostridium difficile infection with fecal microbiota transplantation

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

The microbiome in inflammatory bowel disease: current status and the future ahead

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Induction of colonic regulatory T cells by indigenous Clostridium species

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000908

21 January 2018

Identifiers

10.1097/MIB.0000000000000908

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39435765&oldid=1827887508"